{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:24:17Z","timestamp":1763400257228,"version":"3.28.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,6]]},"DOI":"10.7759\/cureus.73155","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T19:16:00Z","timestamp":1730920560000},"source":"Crossref","is-referenced-by-count":3,"title":["Candidemia Surveillance and Impact on Non-neutropenic Critically Ill Patients"],"prefix":"10.7759","author":[{"given":"Lisa","family":"Hall Zimmerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Dolman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janie","family":"Faris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Mynatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred E","family":"Baylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Tyburski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study","volume":"39","author":"Kett DH","year":"2011","unstructured":"Kett DH, Azoulay E, Echeverria PM, Vincent JL. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med. 2011, 39:665-70. 10.1097\/CCM.0b013e318206c1ca","journal-title":"Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas PG","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, et al.. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009, 48:503-35. 10.1086\/596757","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas PG","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al.. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 62:e1-50. 10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H516","article-title":"Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients","volume":"41","author":"Davis SL","year":"2007","unstructured":"Davis SL, Vazquez JA, McKinnon PS. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother. 2007, 41:568-73. 10.1345\/aph.1H516","journal-title":"Ann Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell M","year":"2005","unstructured":"Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005, 49:3640-5. 10.1128\/AAC.49.9.3640-3645.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/376906","article-title":"A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients","volume":"37","author":"Pappas PG","year":"2003","unstructured":"Pappas PG, Rex JH, Lee J, et al.. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003, 37:634-43. 10.1086\/376906","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus WA","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985, 13:818-29.","journal-title":"Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg BJ","year":"2015","unstructured":"Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015, 373:1445-56. 10.1056\/NEJMra1315399","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31816fc4cd","article-title":"Risk factors for albicans and non-albicans candidemia in the intensive care unit","volume":"36","author":"Chow JK","year":"2008","unstructured":"Chow JK, Golan Y, Ruthazer R, et al.. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med. 2008, 36:1993-8. 10.1097\/CCM.0b013e31816fc4cd","journal-title":"Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes DR","year":"2012","unstructured":"Andes DR, Safdar N, Baddley JW, et al.. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012, 54:1110-22. 10.1093\/cid\/cis021","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp495","article-title":"Candida spp. bloodstream infection: influence of antifungal treatment on outcome","volume":"65","author":"Ortega M","year":"2010","unstructured":"Ortega M, Marco F, Soriano A, Almela M, Mart\u00ednez JA, Pitart C, Mensa J. Candida spp. bloodstream infection: influence of antifungal treatment on outcome. J Antimicrob Chemother. 2010, 65:562-8. 10.1093\/jac\/dkp495","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/11315500-000000000-00000","article-title":"Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients","volume":"69 Suppl 1","author":"Concia E","year":"2009","unstructured":"Concia E, Azzini AM, Conti M. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs. 2009, 69 Suppl 1:5-14. 10.2165\/11315500-000000000-00000","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey KW","year":"2006","unstructured":"Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006, 43:25-31. 10.1086\/504810","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq216","article-title":"A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients","volume":"65","author":"Hsu DI","year":"2010","unstructured":"Hsu DI, Nguyen M, Nguyen L, Law A, Wong-Beringer A. A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients. J Antimicrob Chemother. 2010, 65:1765-70. 10.1093\/jac\/dkq216","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \"missing 50%\" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy CJ","year":"2013","unstructured":"Clancy CJ, Nguyen MH. Finding the \"missing 50%\" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013, 56:1284-92. 10.1093\/cid\/cit006","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-150","article-title":"Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study","volume":"10","author":"Zilberberg MD","year":"2010","unstructured":"Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, Shorr AF. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis. 2010, 10:150. 10.1186\/1471-2334-10-150","journal-title":"BMC Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.4.361","article-title":"Hospital resource utilization and costs of inappropriate treatment of candidemia","volume":"30","author":"Arnold HM","year":"2010","unstructured":"Arnold HM, Micek ST, Shorr AF, Zilberberg MD, Labelle AJ, Kothari S, Kollef MH. Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy. 2010, 30:361-8. 10.1592\/phco.30.4.361","journal-title":"Pharmacotherapy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280516-candidemia-surveillance-and-impact-on-non-neutropenic-critically-ill-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T19:16:02Z","timestamp":1730920562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280516-candidemia-surveillance-and-impact-on-non-neutropenic-critically-ill-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.73155","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,6]]}}}